Dirk Röse

Klasmann-Deilmann vac­ci­na­tes against COVID-19

Inter­nal vac­ci­na­ti­on rate at over 50

The Klasmann-Deilmann Group has laun­ched its own vac­ci­na­ti­on cam­pai­gn. In the cour­se of the first round, more than 100 employees recei­ved the vac­ci­ne from John­son & John­son. The aim is to achie­ve the hig­hest pos­si­ble vac­ci­na­ti­on rate.

Weeks ago, Klasmann-Deil­man­n’s Coro­na Cri­sis Team had alrea­dy pre­pa­red the pro­ce­du­res for its own vac­ci­na­ti­on cam­pai­gn. When the call came from the medi­cal offi­cer, the­re were 48 hours to imple­ment the plan. The actu­al event las­ted only 90 minu­tes. 110 employees of Klasmann-Deilmann and its part­ner com­pa­nies Olde Bol­haar and Deilmann Mon­tan recei­ved the vac­ci­ne from John­son & John­son in the first round. „The­re were hap­py faces ever­y­whe­re that day,” recalls Mana­ging Direc­tor Bernd Weh­ming. „The will to get vac­ci­na­ted in our com­pa­ny is very high. So ever­yo­ne was gra­te­ful that we could make them an offer.”

The goal is to achie­ve the hig­hest pos­si­ble vac­ci­na­ti­on rate wit­hin the Ger­man work­for­ce and also at inter­na­tio­nal level. Alrea­dy today, more than 60 % of employees in Ger­ma­ny and more than 50 % world­wi­de have been vac­ci­na­ted at least once. „In most coun­tries, we have no influ­ence on the imple­men­ta­ti­on of vac­ci­na­ti­ons,” says Mana­ging Direc­tor Moritz Böcking, „becau­se natio­nal stra­te­gies of cour­se have prio­ri­ty. But we have pro­mo­ted the bene­fits of vac­ci­na­ti­on wit­hin the com­pa­ny, and the majo­ri­ty of our col­leagues now want to actively con­tri­bu­te to ending the Coro­na pan­de­mic anyway.”

By July, the com­pany’s inter­nal vac­ci­na­ti­on quo­ta should reach 75 % if pos­si­ble. „Every vac­ci­na­ti­on incre­a­ses the safe­ty of our employees in their pro­fes­sio­nal and pri­va­te lives,” says Moritz Böcking. „A high quo­ta is also an important indi­ca­tor for our inter­nal pro­ces­ses, becau­se it deter­mi­nes, among other things, whe­ther we gra­du­al­ly return to pre­sence mee­tings and busi­ness trips, allow visi­tors or reopen our canteen.”

In the mean­ti­me, the second round of the vac­ci­na­ti­on cam­pai­gn has begun. In par­ti­cu­lar, fema­le employees youn­ger than 50 are now to be vac­ci­na­ted with a sui­ta­ble vac­ci­ne. „We are very gra­te­ful to the medi­cal offi­cers for working clo­se­ly with us,” says Bernd Weh­ming. „And the medi­cal offi­cers are gra­te­ful that we take over the orga­ni­sa­ti­on and make nume­rous vac­ci­na­ti­ons pos­si­ble in the shor­test pos­si­ble time. A com­pa­ny vac­ci­na­ti­on cam­pai­gn is a win-win situa­ti­on for ever­yo­ne involved.”